FULVICIN P/G 330, FULVICIN P/G, FULVICIN P/G 165
CHARTWELL RX · GRISEOFULVIN, ULTRAMICROSIZE
Open FDA's page for this record- Application number
- ANDA061996
- Sponsor name
- CHARTWELL RX
- Submissions
- Submission type
- SUPPL
- Submission number
- 7
- Submission status
- AP
- Submission status date
- 20010126
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 19820406
- Submission type
- SUPPL
- Submission number
- 9
- Submission status
- AP
- Submission status date
- 20260901
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Products
- Product number
- 004
- Reference drug
- No
- Brand name
- FULVICIN P/G 330
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- GRISEOFULVIN, ULTRAMICROSIZE
- Strength
- 330MG
- Product number
- 002
- Reference drug
- No
- Brand name
- FULVICIN P/G
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- GRISEOFULVIN, ULTRAMICROSIZE
- Strength
- 250MG
- Product number
- 003
- Reference drug
- No
- Brand name
- FULVICIN P/G 165
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- GRISEOFULVIN, ULTRAMICROSIZE
- Strength
- 165MG
- Product number
- 001
- Reference drug
- No
- Brand name
- FULVICIN P/G
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- GRISEOFULVIN, ULTRAMICROSIZE
- Strength
- 125MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA061996
- Brand name
- ULTRAMICROSIZE GRISEOFULVIN
- Generic name
- ULTRAMICROSIZE GRISEOFULVIN, GRISEOFULVIN
- Manufacturer name
- Chartwell RX, LLC, Chartwell RX, LLC., Ayurax, LLC., Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- Product NDC
- 62135-501, 62135-494, 62135-495, 73308-435, 23155-863, 23155-864
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- GRISEOFULVIN
- RxCUI
- 245248, 239239, 242831
- SPL ID
- 2e9858c1-8c99-8a0d-e063-6294a90a59a5, 459d8a07-072f-744c-e063-6394a90a9d87, 2d3fc650-5035-982f-e063-6394a90a6fd4, db35c070-b434-48f2-8ce8-e902d498459a
- SPL set ID
- 640c489e-f491-4805-a390-ef4be43e261b, efb8a660-802c-4ca6-bbff-ad7b48b91aef, 43fc5201-d23c-4d83-9247-baefe03774ef, ae369582-2e4c-48a4-ac42-0a77466654fd
- Package NDC
- 62135-501-30, 62135-494-01, 62135-494-30, 62135-495-01, 62135-495-30, 73308-435-30, 23155-863-01, 23155-864-01
- Nui
- N0000008732, N0000175085, N0000175848
- Pharm class pe
- Decreased Mitosis [PE], Microtubule Inhibition [PE]
- Pharm class epc
- Tubulin Inhibiting Agent [EPC]
- UNII
- 32HRV3E3D5
